AstraZeneca wins U.S. approval for longer use of blood thinner
 

AstraZeneca wins U.S. approval for longer use of blood thinner
(Reuters) - U.S. regulators have approved a new dose of AstraZeneca's blood thinner Brilinta for longer-term use in patients with a history of heart attacks, boosting prospects for a drug the company thinks will eventually sell $3.5 billion a year.


http://rc.feedsportal.com/r/23838524...28/rc/1/rc.img

http://rc.feedsportal.com/r/23838524...28/rc/2/rc.img

http://rc.feedsportal.com/r/23838524...28/rc/3/rc.img

http://da.feedsportal.com/r/23838524...d/sc/28/a2.img
http://adchoice.feedsportal.com/r/23.../sc/28/ach.imghttp://pi.feedsportal.com/r/23838524.../sc/28/a2t.imghttp://pi2.feedsportal.com/r/2383852...sc/28/a2t2.imghttp://i1.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...I0:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...I0:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/nR1pkgWmBX0